Natural options for management of melasma, a review

References

• Draelos ZD. The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups. J Cosmet Dermatol. 2006;5:239–44. doi:10.1111/j.1473-2165.2006.00260.x.
   PubMedGoogle Scholar
• Yao C, Oh J, Oh IG, Park C, Chung JH. [6]-Shagaol inhibits melanogenesis in B16 mouse melanoma cells through activation of the ERK pathway. Acta Pharmacological Sinica. 2013;34:289–94. doi:10.1038/aps.2012.134.
   Google Scholar
• Solano F, Bringati PM, Ghahem G. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res. 2006;90:550–71. doi:10.1111/j.1600-0749.2006.00334.x.
   Google Scholar
• Fu B, Li H, Wang X, Lee FS, Cui S. Isolation and identification of flavonoids in licorice and a study of their inhibitory effect on tyrosinase. J Agric Food Chem. 2005;53:7408–744. doi:10.1021/jf051258h.
   PubMed Web of Science ®Google Scholar
• Boissy RE. Melanosome transfer to and translocation in the keratinocytes. Exp Dermatol. 2003;12:5–12. doi:10.1034/j.1600-0625.12.s2.1.x.
   PubMed Web of Science ®Google Scholar
• Smit N, Vicanova J, Pavel S. The hunt for natural skin whitening agents. Int J Mol Sci. 2009;10(12):5326–49. doi:10.3390/ijms10125326.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55:1048–65.
   PubMed Web of Science ®Google Scholar
• Ortonne JP, Balloti R. Melanocytic biology and melanogenesis: what’s new? J Dermatol Treat. 2000;11:S15–16.
   Web of Science ®Google Scholar
• Yaar M, Gilchrest BA. Melanocytic biology: before, during and after the Fitzpatrick era. J Invest Dermatol. 2004;122:xvii–xxix.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay D. Topical treatment of melasma. Indian J Dermatol. 2009;54:303–09. doi:10.4103/0019-5154.57602.
   PubMed Web of Science ®Google Scholar
• Vachiramon V, Suchonwanit P, Thadanipot K. Melasma in men. J Cosmet Dermatol. 2012;11:151–57. doi:10.1111/j.1473-2165.2012.00613.x.
   PubMed Web of Science ®Google Scholar
• Sialy R, Hassan I, Kaur I, Dash RJ. Melasma in men: a hormonal profile. J Dermatol. 2000;27:64–65. doi:10.1111/j.1346-8138.2000.tb02122.x.
   PubMedGoogle Scholar
• Haddad AL, Matros LF, Brunstein F, Ferreira LM, Silva M, Costa D Jr. A clinical prospective, randomised, double-blind trial comparing skin whitening complex with HQ vs. placebo in the treatment of melasma. Int. J. Dermatol. 2003;42(2):153–56. doi:10.1046/j.1365-4362.2003.01621.x.
   PubMed Web of Science ®Google Scholar
• Grimes PE. The safety and efficacy of salicylic acid chemic peels in darker racial-ethnic groups. Am Soc Dermatologic Surgery. 1999;25:18–22. doi:10.1046/j.1524-4725.1999.08145.x.
   PubMed Web of Science ®Google Scholar
• Alam M, Pongprutthipan M. Body Rejuvenation. London: Springer Science+ Business; 2010. p. 239–43.
   Google Scholar
• Battle EF, Soden CE. The use of lasers in darker skin types. In Seminars in cutaneous medicine and surgery. 2009;28(2):130-140. Frontline Medical Communications.
   Google Scholar
• Grimes P. Aesthetics and cosmic surgery for darker skin types. USA: Lippincott Williams &Wilkins; 2008. p. 117-118, 49-51, 75-80.
   Google Scholar
• Edalatkhah H, Amani F, Rezaifar G. Prevalence of melasma in women in Ardebil city in 2002. Iran J Dermatol. 2004;7:72–77.
   Google Scholar
• El-Essawi D, Musial JL, Hammad A, Lim HW. A survey of skin disease and skin related issues in Arab Americans. J Am Acad Dermatol. 2007;56:933–38. doi:10.1016/j.jaad.2007.01.031.
   PubMed Web of Science ®Google Scholar
• Werlinger KD, Guevara L, González CM, Edward TR, Caetano R, Haley RW, Pandya AG. Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, Tex. Arch Dermatol. 2007;143(3):423–31. doi:10.1001/archderm.143.3.424.
   PubMedGoogle Scholar
• Song M, Mun JH, Ko HC, Kim BS, Kim MB. Korean red ginseng powder in the treatment of melasma: an uncontrolled observational study. J Ginseng Res. 2011;35:170–75. doi:10.5142/jgr.2011.35.2.170.
   PubMed Web of Science ®Google Scholar
• Balkrishnan R, McMichael AJ, Camacho FT. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003;149:572–77. doi:10.1046/j.1365-2133.2003.05419.x.
   PubMed Web of Science ®Google Scholar
• Pawaskar M, Parikh P, Markowski T, Mcmichael AJ, Feldman SR, Balkrishnan R. Melasma and its impact on health-related quality of life in Hispanic women. J Dermatolog Treatment. 2007;18:5–9. doi:10.1080/09546630601028778.
   PubMed Web of Science ®Google Scholar
• Cestari T, Hexsel D, Viegas M, Azulay M, Hassun K, Almeida ART, Rêgo VR, Mendes AM, Filho JW, Junqueira H. Validation of melasma quality of life questionnaire for Brazilian Portuguese language: the melasqol-bp study and improvement of qol of melasma patients after triple combination therapy. Br J Dermatol. 2007;156:13–20. doi:10.1111/j.1365-2133.2006.07591.x.
   PubMed Web of Science ®Google Scholar
• Halder RM, Rodney IJ. Why are there so few effective treatments for pigmentary disorders of the skin? Expert Rev Dermatol. 2012;7(2):109–12. doi:10.1586/edm.12.9.
   Google Scholar
• Tamega Ade A, Miot LD, Bonfietti C, Gige TC, Marques ME, Miot HA. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013;27:151–56. doi:10.1111/j.1468-3083.2011.04430.x.
   PubMed Web of Science ®Google Scholar
• Ortone JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P, Hexsel D, Im S, Lim J, Lui H, et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009;23:1254–62. doi:10.1111/j.1468-3083.2009.03295.x.
   PubMed Web of Science ®Google Scholar
• Hexcel D, Lacerda DA, Cavalcante AS, Machado Fiho CA, Kalil CLPV, Ayres EL, Azulay-Abulafia L, Weber MB, Serra MS, Lopes NF, et al. Epidemiology of melasma in Brazilian patents: a multicenter study. Int J Dermatol. 2013;53:440–44. doi:10.1111/j.1365-4632.2012.05748.x.
   PubMed Web of Science ®Google Scholar
• Handel AC, Lima PB, Tonolli VM, Miot LDB, Miot HA. Risk factors for facial melasma in women: a case-control study. Br J Dermatol. 2014;171:588–94. doi:10.1111/bjd.2014.171.issue-3.
   PubMed Web of Science ®Google Scholar
• Hann SK, Im S, Chung WS, Kim Do Y. Pigmentary disorders in the South East. Dermatol Clin. 2007;25:431–38. doi:10.1016/j.det.2007.04.002.
   PubMed Web of Science ®Google Scholar
• Ni Z, Mu Y, Gulati O. Treatment of melasma with Pycnogenol. Phytother Res. 2002;16:567–71. doi:10.1002/ptr.1085.
   PubMed Web of Science ®Google Scholar
• Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, Sohn S, Im S. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146(2):228–37. doi:10.1046/j.0007-0963.2001.04556.x.
   PubMed Web of Science ®Google Scholar
• Grimes P, Yamada N, Bhawan J. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol. 2005;27:96–101. doi:10.1097/01.dad.0000154419.18653.2e.
   PubMed Web of Science ®Google Scholar
• Tse TW, Hui E. Tranexamic acid: an important adjuvant in the treatment of melasma. J Cosmet Dermatol. 2013;12:57–66. doi:10.1111/jocd.2013.12.issue-1.
   PubMed Web of Science ®Google Scholar
• SA statistical Release P0 302 mid- year population estimates [online] Available at: https://www.statssa.gov.za/publications/P0302/P03022016.pdf [ Accessed 21 September 2017].
   Google Scholar
• Shankar K, Godse K, Aurangabadkar S, Lahiri K, Mysore V, Ganjoo A, Vedamurty M, Kohli M, Sharad J, Kadhe G, et al. Evidence-based treatment for melasma: expert opinion and a review. Dermatol Ther December. 2014;4(2):165–86. doi:10.1007/s13555-014-0064-z.
   PubMedGoogle Scholar
• Talakoub L. Wesley NO. Differences in perceptions of beauty and cosmetic procedures performed in ethnic patients. In Seminars in cutaneous medicine and surgery. 2009;28(2):115-129. Frontline Medical Communications.
   Google Scholar
• Grimes. P. Aesthetics and cosmic surgery for darker skin types. USA: Lippincott Williams &Wilkins; 2008. p. 117–118, 49–51, 75–80.
   Google Scholar
• Goh CL, Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J. 1999;40:455–58.
   PubMedGoogle Scholar
• Ponzio HA, Cruz M. Acurácia do exame sob a lâmpada de Wood na classificação dos cloasmas. An Bras Dermatol. 1993;68:325–28.
   Google Scholar
• Rendon MI, Gaviria JI. Review of skin- lightening agents. Am Soc Dermatologic Surgery. 2005;31:886–89. doi:10.1111/j.1524-4725.2005.31736.
   PubMed Web of Science ®Google Scholar
• Zhu W, Gao J. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Investigative Dermatol Symp Proc. 2008;13:20–21. doi:10.1038/jidsymp.2008.8.
   PubMedGoogle Scholar
• Huh CH, Seo KI, Park YJ, Lim JG, Eun HC, Park KC. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatology, 2003;206(4):316–320.
   PubMed Web of Science ®Google Scholar
• Katsube T, Imawaka N, Kawano Y, Yamazakib Y, Shiwakuc K, Yamane Y. Antioxidant flavonol glycosides in mulberry (Morus alba L) leaves isolated based on LDL antioxidant activity. Food Chem. 2006;97:25–3. doi:10.1016/j.foodchem.2005.03.019.
   Web of Science ®Google Scholar
• Ebanks JP, Wickett RR, Raymond EB. Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. Int J Mol. 2009;10:4066–87. doi:10.3390/ijms10094066.
   Google Scholar
• Taylor MB, Yanaki JS, Draper DO, Shurtz JC, Coglianese M. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen. J Drugs in Dermatol. 2013;12(1):45–50.
   PubMed Web of Science ®Google Scholar
• Balevi A, Ustuner P, Özdemir M. Salicylic acid peeling combined with vitamin C mesotherapy versus salicylic acid peeling alone in the treatment of mixed type melasma: A comparative study. Journal of Cosmetic and Laser Therapy.2017;19 (5):294–299.
   Google Scholar
• Lee GSK. Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report. J Cosmet Laser Ther. 2008;10:234–36. doi:10.1080/14764170802187193.
   PubMed Web of Science ®Google Scholar
• Lee MC, Chang SC, Huang YL, Chang SL, Chang CH, Lin YF, Hu S. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd: YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study. Lasers Med Sci. 2015;301:159–63. doi:10.1007/s10103-014-1608-2.
   Google Scholar
• Zhou HL, Hu B, Zhang C. Efficacy of 694-nm fractional Q-switched ruby laser (QSRL) combined with sonophoresis on levorotatory vitamin C for treatment of melasma in Chinese patients. Lasers Med Sci. 2016;315:991–95. doi:10.1007/s10103-016-1938-3.
   Google Scholar
• Espinal-Perez LE, Moncada B, Castanedo-Cazares JP. A double-blind randomised trial of 5% ascorbic acid vs. 4% hydroquione in melasma. Int J Dermatol. 2004;43:604–07. doi:10.1111/j.1365-4632.2004.02134.x.
   PubMed Web of Science ®Google Scholar
• Deo SK, Dash KN, Sharma YK, Virmani NC, Oberai C. Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma: a randomized, single blind, comparative study of efficacy and safety. Indian J Dermatol. 2013;58(4):281. doi:10.4103/0019-5154.113940.
   PubMedGoogle Scholar
• Halder RM, Richards GM. Management of dyschromias in ethnic skin. Dermatol Ther. 2004;17:151–57. doi:10.1111/dth.2004.17.issue-2.
   PubMedGoogle Scholar
• Monteiro RC, Kishore BN, Bhat RM, Sukumar D, Martis J, Ganesh HK. A comparative study of the efficacy of 4% hydroquinone vs 0.75% Kojic acid cream in the treatment of facial melasma. Indian J Dermatol. 2013;58:2:157. doi:10.4103/0019-5154.108070.
   PubMedGoogle Scholar
• Leyden JJ, Shergill B, Micali G, Downie J, Wallo W. Natural options for the management of hyperpigmentation. J Eur Acad Dermatol Venereol. 2011;25:1140–45. doi:10.1111/j.1468-3083.2011.04130.x.
   PubMed Web of Science ®Google Scholar
• Paine C, Sharlow E, Liebel F, Eisinger M, Shapiro S, Seiberg M. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. I Invest Dermatol. 2001;116:587–95. doi:10.1046/j.1523-1747.2001.01291.x.
   PubMed Web of Science ®Google Scholar
• Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, Greatens A, Hillebrand GG, Bissett DL, Boissy RE. The effects of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147:20–31. doi:10.1046/j.1365-2133.2002.04834.x.
   PubMed Web of Science ®Google Scholar
• Amer M, Metwalli M. Topical liquiritin improves melasma. Int J Dermatol. 2000;39:299–301. doi:10.1046/j.1365-4362.2000.00943.x.
   PubMed Web of Science ®Google Scholar
• Toosi P, Esmaili AM, Saeedi M. Evaluation of licorice efficacy on melasma. Iran J Dermatol. 2013;16, 3 ( 65):118–119.
   Google Scholar
• Shamsi Meymandi S, Mohammadzadeh Shanehsaz S, Ansari Dogaheh M. Efficacy of licorice extract in the treatment of melasma: a randomized, double-blind, placebo-controlled clinical trial. J Dermatol Cosmet. 2016;7(1):1–9.
   Google Scholar
• Davis EC, Callender V. Post inflammatory hyperpigmentation, a review of the epidemiology, clinical features and treatment options in kin of color. J Clin Aesthet Dermtol. 2010;3(7):20–31.
   PubMedGoogle Scholar
• Keeling J, Cardona L, Benitez A, Epstein R, Rendon M. Mequinol 2%/tretinoin 0.01% topical solution for treatment of melasma in men: a case series and review of the literature. Cutis. 2008;81:179–83.
   PubMed Web of Science ®Google Scholar
• Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, Oros-Ovalle C, Fuentes-Ahumada C, González FJ, Martínez-Ramírez JD, Moncada B. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatology research and practice, vol. 2011, Article ID 379173, 5 pages, 2011.
   Google Scholar
• Minwalla L1, Zhao Y, Cornelius J, Babcock GF, Wickett RR, Le PIC, Boissy RE. Inhibition of melanosome transfer from melanocytes to keratinocytes by lectins and neoglycoproteins in an in vitro model system. Pigment Cell Res. 2001;14(3):185–94.
   PubMedGoogle Scholar
• Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness and hyperpigmented spots in aging facial skin. Int J Cosmet Sci. 2004;26:231–38.
   PubMedGoogle Scholar
• Iraji F, Mehrpour K, Asilian A, Siadat AH, Mohaghegh F. A Comparituve study to evaluate the efficacy of 4% N-acetyl glucosamine + 2% nicotinamide cream versus 4% hydroquinone cream in the treatment of facial melasma: a randomized, double-blind, split face clinical trial. J Tissue Res. 2009;9(1):1767.
   Google Scholar
• Kimball AB, Kaczvinsky JR, Li J, Robinson LR, Matts PJ, Berge CA, Miyamoto K, Bissett DL. Reduction in the appearance of hyperpigmentation after use of moisturisers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomised, double blind, vehicle controlled trial. Br J Dermatol. 2010;162:435–41.
   PubMed Web of Science ®Google Scholar
• Baliña LM, Graupe K. The treatment of melasma 20% azelaic acid versus 4% HQ cream. Int J Dermatol. 1991;30(12):893–95.
   PubMed Web of Science ®Google Scholar
• Polnikorn N. Treatment of refractory melasma with the MedLite C6 Q-switched Nd: YAG laser and alpha arbutin: a prospective study. J Cosmet Laser Ther. 2010;12(3):126–31.
   PubMed Web of Science ®Google Scholar
• Han TY, Son IP, Jang WS, Chang HS, Kim JH, Sim YH, Kim DH, Kim BJ, Kim MN, Lee HK, et al. Efficacy of hydrogel mask with 2% arbutin for melasma. Korean J Dermatol. 2011;49(3):210–16.
   Google Scholar
• Ertam I, Mutlu B, Unal I, Alper S, KivCAk B, Ozer O. Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open‐label study. J Dermatol. 2008;35(9):570–74.
   PubMed Web of Science ®Google Scholar
• Chawla S, DeLong MA, Visscher MO, Wickett RR, Manga P, Boissy RE. Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives. Br J Dermatol. 2008;159(6):1267–74.
   PubMed Web of Science ®Google Scholar
• Picardo M, Carrera M. New and experimental treatments of cloasma and other hypermelanoses. Elsevier. 2007;25(3):353–62.
   Google Scholar
• Hamed SH, Sriwiriyanont P, deLong MA, Visscher MO, Wickett RR, Bossy RE. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent. J Cosmet Sci. 2006;57:291–308.
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Nishimura T, Nomura K, Sugimoto K, Kuriki T. Inhibitory effects of alpha-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model. Biol Pharm Bull. 2004;27:510–14.
   PubMed Web of Science ®Google Scholar
• Boissy RE, Visscher M, DeLong MA. Deoxyarbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol. 2005;14:601.
   PubMed Web of Science ®Google Scholar
• Jones K, Hughes J, Hong M, Jia Q, Orndorff S. Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Res. 2002;15:335–40.
   PubMedGoogle Scholar
• Choi S, Park AI, Lee SK, Kim JE, Chung MH. Aloesin inhibits hyperpigmentation induced by UV radiation. Clin Exp Dermatol. 2002;27:513–15.
   PubMed Web of Science ®Google Scholar
• Lee SH, Choi SY, Kim H, Hwang JS, Lee BG, Gao JJ, Kim SY. Mulberroside F isolated from the leaves of morus alba inhibits melanin biosynthesis. Biol Pharm Bull. 2002;25:1045–48.
   PubMed Web of Science ®Google Scholar
• Alvin G, Catambay N, Vergara A, Jamora MJ. A comparative study of the safety and efficacy of 75% mulberry (Morus alba) extract oil versus placebo as a topical treatment for melasma: a randomized, single-blind, placebo-controlled trial. J Drugs in Dermatol. 2011;10(9):1025–31.
   PubMed Web of Science ®Google Scholar
• Barbulova A, Colucci G, Apone F. New trends in cosmetics: by-products of plant origin and their potential use as cosmetic active ingredients. Cosmetics. 2015;2:82–92.
   Google Scholar
• Kim SS, Kim MJ, Choi YH, Kim BK, Kim KS, Park KJ, Park SM, Lee NH, Hyun GG. Down-regulation of tyrosinase, TRP-1, TRP-2 and MITF expressions by citrus press-cakes in murine B16 F10 melanoma. Asian Pac. J. Trop. Biomed. 2013;3:617–22.
   PubMedGoogle Scholar
• Kim B, Lee YJ, Lee HY, Nam KY, Park J, Lee SM, Kim JE, Lee JD, Hwang JS. Hesperidin suppresses melanosome transport by blocking the interaction of Rab27A-melanophilin. Biomol. Ther. Seoul. 2013;21:343–48.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee WJ, Chang SE, Lee GY. Hesperidin, a popular antioxidant inhibits melanogenesis via Erk1/2 mediated MITF degradation. Int J Mol Sci. 2015;16(8):18384–95.
   PubMed Web of Science ®Google Scholar
• Proteggente AR, Basu-Modak S, Kuhnle G, Gordon MJ, Youdim K, Tyrrel R, Rice-Evans CA. Hesperetin glucuronide, a photoprotective agent arising from flavonoid metabolism in human skin fibroblast. Photochem Photobiol. 2003;78:256–61.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Simuyoshi M, Sakanaka M. Effects of ginsenosides Rb1 on skin changes. J Biomed Biotehnol. 2012;2012:94624.
   Google Scholar
• Kim K. Effects of ginseng and ginsenosides on melanogenesis and their mechanism of action. J Ginseng Res. 2015;39(1):1–6.
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim KT, Kim SS, Hur J, Ha SK, Cho CW, Choi SY. Inhibitory effects of ginseng seed on melanin biosynthesis. Pharmacogn Mag. 2014;10(Suppl. 2):S272e5.
   Google Scholar
• Hwang EY, Kong YH, Lee YC, Kim YC, Yoo KM, Jo YO, Choi SY. Comparison of phenolic compounds contents between white and red ginseng and their inhibitory effect on melanin biosynthesis. J Ginseng Res. 2006;30:82e7.
   Google Scholar
• Garcia-Lopez, M. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol (Stockh), 1989;143:58–61.
   Google Scholar
• Baliña LM, Graupe K. The treatment of melasma 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991;30(12):893–95.
   PubMed Web of Science ®Google Scholar
• Mazimba O. Umbelliferone: Sources, chemistry and bioactivities review. Bulletin of Faculty of Pharmacy, Cairo University. 2017;55(2):223–232.
   Google Scholar
• Ashraf Z, Rafiq M, Seo SY, Babar MM, Zaidi NUSS. Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors. J Enzyme Inhib Med Chem. 2015;30(6):874–83.
   PubMed Web of Science ®Google Scholar
• Yamakoshi J, Sano A, Tokutake S, Saito M, Kikuchi M, Kubota Y, Kawachi Y, Otsuka F. Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma. Phytother Res. 2004;18:895–99.
   PubMed Web of Science ®Google Scholar
• Victor F, Gelber J, Rao B. Melasma: a Review. J Cutaneous Med Surgery: inc Med Surg Dermatol. 2004;2:94–102.
   Google Scholar
• Katsambas A, Antoniou CH. Melasma. Classification and treatment. J Eur Acad Dermatol Venereol. 1995;4:217–23.
   Google Scholar
• Mahmoud BH, Ruvolo E, Hexsel CL, Liu Y, Owen MR, Kollias N, Lim HW, Hamzavi IH. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010;130:2092–97.
   PubMed Web of Science ®Google Scholar
• Mahmoud BH, Hexsel CL, Hamzavi IH, Lim WH. Review, effects of visible light on the skin. Photochem Photobiol. 2008;84:450–62.
   PubMed Web of Science ®Google Scholar
• Purim KS, Avelar MF. [Photoprotection, melasma and quality of life in pregnant women]. Rev Bras Ginecol Obstet. 2012;34:228–34.
   PubMedGoogle Scholar
• Costa MC, Eljaiek HV, Abraham LS, Azulay-Abulafia L, Ardigo M. In vivo reflectance confocal microscopy in a typical case of melasma. An Bras Dermatol. 2012;87:782–84. doi:10.1590/S0365-05962012000500021.
   PubMed Web of Science ®Google Scholar
• Buller DB, Cokkinides V, Hall HI, Hartman AM, Saraiya M, Miller E, Paddock L, Glanz K. Prevalence of sunburn, sun protection, and indoor tanning behaviors among Americans: review from national surveys and case studies of 3 states. J Am Acad Dermatol. 2011;65(5):S114–e1. doi:10.1016/j.jaad.2011.05.033.
   PubMed Web of Science ®Google Scholar